Trial search - ClinicalTrials.eu

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

Study on Stopping CDK4/6 Inhibitors in Patients with Metastatic HR Positive, HER2 Negative Breast Cancer Using Abemaciclib, Letrozole, and Fulvestrant

Recruiting

1 1 1
Investigated diseases:
- Hormone receptor positive breast cancer
Investigated drugs:
Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Recruiting

1 1 1 1
Investigated drugs:
+7
Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

Recruiting

1 1 1 1
Investigated diseases:
- Breast cancer female
- Hormone receptor positive breast cancer
Investigated drugs:
Study on Elacestrant and Triptorelin for Premenopausal Women with Early Luminal Breast Cancer

Recruiting

1 1 1
Investigated diseases:
- Hormone receptor positive breast cancer
Investigated drugs:
Study on Cannabidiol for Joint Pain in Early Breast Cancer Patients on Hormone Therapy

Not yet recruiting

1 1
Investigated diseases:
- Breast cancer
- Hormone receptor positive breast cancer
Investigated drugs:
- Cannabidiol
Study on Everolimus and Exemestane for Patients with Metastatic Breast Cancer

Not yet recruiting

1 1 1
Investigated diseases:
- HER2 negative breast cancer
Investigated drugs:
- Everolimus
- Exemestane
Study Comparing 18F-FDG and 68Ga-FAPI-46 for PET Scans in Patients with Hormone-Positive Breast Cancer

Not yet recruiting

1 1
Investigated diseases:
- Hormone receptor positive breast cancer
Investigated drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Study on Cannabidiol for Joint Pain in Early Breast Cancer Patients on Hormone Therapy

Not yet recruiting

1 1
Investigated diseases:
- Hormone receptor positive breast cancer
Investigated drugs:
- Cannabidiol
Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

Not recruiting

1 1 1 1
Investigated diseases:
- Hormone receptor positive breast cancer
Investigated drugs:
+6
Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

Not recruiting

1 1 1
Investigated drugs:
- Palbociclib
+5

Find clinical trials in your area

Matched clinical trials

We use cookies